Explains specific technical bottlenecks in applying AI to the 10-15 year drug development pipeline and how Anthropic's Claude and Chai's molecular design platform are targeting them, giving engineers building in AI-for-science a view of where the real friction is.
“China cannot run faster than AI.”
Josh
“You could have a single person using lots and lots of Claude and foundation models actually running a portfolio of early stage drug programs.”
Eric
“the tools are becoming more valuable than they've ever been before.”
Josh
articleHow Building Software Is Changing at AnthropicGergely Orosz
article🔬Causal Models Need Causal Data - Xaira’s X-Cell model for Drug Discovery (Bo Wang & Ci Chu, Chief Discovery Officer & Chief AI Scientist)RJ Honicky
podcastAnthropic’s first technical PM on token maxing, the jagged edge, and living in the future | Dianne PennLenny RachitskySign in to comment.
Loading comments…